Home / Inspections / 1217041

FDA Inspection 1217041 — Creative Testing Solutions

Creative Testing Solutions — FEI 1000305305

The FDA completed an inspection of Creative Testing Solutions on August 31, 2023 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 31, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Saint Louis, MO (United States)

Facility

Other inspections at this facility

  • 1017388 (NAI Wed Jun 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 972933 (NAI Fri Jun 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 943401 (NAI Thu Jul 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 879151 (NAI Fri May 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 837851 (NAI Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources